Daniels, Brodie
Wand, Handan
Ramjee, Gita
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Implementation and Appraisal of a Novel Confirmatory HIV-1 Testing Algorithm in the Microbicides Development Programme 301 Trial (MDP301)
https://doi.org/10.1371/journal.pone.0042322
Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa
https://doi.org/10.1186/s13104-016-2319-5
“One Teabag Is Better than Four”: Participants Response to the Discontinuation of 2% PRO2000/5 Microbicide Gel in KwaZulu-Natal, South Africa
https://doi.org/10.1371/journal.pone.0014577
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
https://doi.org/10.1016/s0140-6736(10)61086-0
Funding for this research was provided by:
Department for International Development (G0100137)
Medical Research Council (G0100137)
Article History
Received: 13 April 2016
Accepted: 1 December 2016
First Online: 12 December 2016